Shimadzu announces the completion of the new Quality Center building, which has been under construction at its head office (Sanjo Works) premises since February 2013. The Quality Center has been constructed to improve the quality of products developed and manufactured by Shimadzu. It consol ... more
Shimadzu acquires specialist for isotope labeled standards
Shimadzu has joined forces with the France-based AlsaChim company, an independent contract research and development organization. AlsaChim specializes in stable isotope-labelled compounds, metabolites and pharmaceutical related substances, and analytical purposes. With immediate effect, Shimadzu Europe has acquired AlsaChim by 100%.The brand name will be kept for the future complemented by the subtitle “a Shimadzu Group Company”. The price for the acquisition is kept confidential.
Through the acquisition of AlsaChim, Shimadzu also adds value to its European Innovation Center (EUIC), particularly for the clinical segments which is one of EUIC’s focus areas. This innovations-oriented Think Tank combines academic-scientific expertise from well-known European universities with Shimadzu’s cutting-edge technology to provide even more customer-focused service.
“With AlsaChim, we have a strong partner in our organization who is able to finalize and validate new application kits and utilize the developments done by EUIC and transfer them into ready-to-use products”, said Bjoern-Thoralf Erxleben, Senior Manager Analytic Shimadzu Europa, based in Duisburg, Germany.
Shimadzu and AlsaChim expect new customers for both brands. The EUIC and its strong cooperation partners provide a platform for new and additional business. Having with AlsaChim a strong partner for development of application kit solutions, this will increase Shimadzu’s business in the clinical and diagnostic market, but also in other market segments. “Being part of the Shimadzu Group, the AlsaChim brand expects additional demand for their products in new sales areas as well as stronger marketing support than before”, said Jean-Francois Hoeffler, President of AlsaChim.
- isotope labeled compounds
- analytical standards
Shimadzu has created a new Laboratory World for its customers from all over Europe. The Laboratory World is located at Shimadzu’s European headquarters in Duisburg, Germany. On an area greater than 1,500 m2, testing facilities are available for Shimadzu’s entire product range – from chromat ... more
Shimadzu UK Ltd is continuing the company’s programme of investment in the molecular and atomic spectroscopy markets by appointing Andy Winn as a Product Specialist for atomic absorption (AA), inductively coupled plasma (ICP) and total organic carbon (TOC) in Shimadzu UK’s Spectroscopy Grou ... more
Lowest injection volumes, long service life thanks to increased sensitivity. ✓ Lowest detection limits and reliable results even in the ultra-trace range. ✓ Precise processing - fast and easy operation with the user-friendly software more
Efficient self-regeneration and better peak shape, thanks to patented suppressor membrane folding technology. ✓ Highly reliable results due to a robust system with minimal carryover. ✓ Ion chromatograph in compact design that saves expensive bench space in the laboratory. more
You can benefit from over 40 years of experience in liquid chromatography and rely on the new ion chromatograph from Shimadzu - one system, three key features: robust, powerful, space-saving. The innovative and patented membrane folding technology of the suppressor offers two advantages: Du ... more
- 1Detect neurodegenerative diseases such as Alzheimer's by a simple eye scan?
- 2Fluorescence microscopy at highest spatial and temporal resolution
- 3The Mechanics of the Immune System
- 4Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis
- 5Quick look under the skin
- 6New ion trap to create the world's most accurate mass spectrometer
- 7How does your computer smell?
- 8Clocking electron movements inside an atom
- 9Sartorius closes 2020 with strong growth
- 10A clear path to better insights into biomolecules